Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00718302 · ClinicalTrials.gov registry record · NA

A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures

A NA study, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
249
Enrollment target

NCT00718302: Completed NA study, sponsored by Boston Medical Center.

NCT00718302 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 249 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00718302, a NA study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
249 participants
Enrollment target

Study Summary

The role of operative fixation of unstable, displaced lateral malleolus fractures is well-established (Mayer, Mak, and Yablon). However, the optimal type of fixation remains the subject of debate. Lag screw fixation alone is only appropriate for long oblique fractures in younger patients (Tornetta). For all other patients, the choices for fibular stabilization most commonly involve the use of plates and screws which can be placed on either the lateral or posterior side of the bone, with or without lag screws. Lateral plating remains the most popular option, but since the description of posterior plating in 1982 (Brunner), reports in the literature have demonstrated some advantages of posterior over lateral plating (Ostrum, Treadwell, Winkler, and Wissing) . These advantages include less dissection, less palpable hardware, and decreased likelihood of intra-articular screw placement. However, there is only a single retrospective study in the published literature directly comparing these two methods (Lamontagne).

Primary Outcome

Percentage of Participants with Nonpalpable Hardware

Interventions

  • DEVICE Antiglide Plate
  • DEVICE Lateral Plate

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2008-06
Est. Completion 2012-12
Phase NA
Boston Medical Center

253 total trials

What the finished NCT00718302 record still lists

NCT00718302 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 2 interventions - of which Antiglide Plate is the first listed.

NCT00718302 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00718302 about?

NCT00718302 is a clinical study titled "A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures". The role of operative fixation of unstable, displaced lateral malleolus fractures is well-established (Mayer, Mak, and Yablon). However, the optimal type of fixation remains the subject of debate. Lag screw fixation alone is only appropriate for long oblique fractures in younger patients (Tornetta)....

What is the current status of trial NCT00718302?

This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2008-06. Estimated completion is 2012-12.

What interventions are being tested in trial NCT00718302?

The interventions under investigation include: Antiglide Plate (DEVICE), Lateral Plate (DEVICE).

Who is sponsoring clinical trial NCT00718302?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00718302's enrollment target sits among peer trials

249 434th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04628767 · 249 participants · Phase 2

    Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

  • NCT05834907 · 249 participants · NA

    Hands and Hearts Together

  • NCT06067555 · 249 participants · Early Phase 1

    Intradermal Influenza Vaccination

  • NCT06588478 · 249 participants · Phase 2

    A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00718302, the US trial registry maintained by the National Library of Medicine. NCT00718302 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.